|
|
|||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Received on June 14, 2006
Accepted on November 30, 2006
Lipids, Lipoproteins, and Cardiovascular Risk Factors |
1 Departments of Medicine and Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL
2 Department of Medicine and Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL
* To whom correspondence should be addressed. E-mail: psubbaiah{at}uic.edu.
Background: Isoprostane F2
(iPF2
-III) concentration in plasma and urine is widely accepted as a measure of oxidative stress. Gas chromatography-mass spectroscopy (GC/MS) methods for measuring iPF2
-III involve several steps of sample preparation and are labor-intensive and ELISA methods, although easier to use, are less reliable. Therefore we developed a simple and sensitive method involving 1-step sample cleanup and HPLC/MS quantification.
Methods: Samples of plasma or urine were enriched with a deuterated (iPF2
-III-D4) standard, treated with KOH to liberate the bound isoprostanes,then loaded onto an immunoaffinity column, and the bound isoprostane was eluted with 95% ethanol. The concentrated sample was injected onto a C-18 HPLC column, and the isoprostane was eluted with a gradient of acetonitrile in water and analyzed by electrospray negative ionization, selectively monitoring the ions 353.2 (iPF2
-III) and 357.2 (iPF2
-III-D4). The amount of isoprostane in the sample was calculated from the ratio of the intensities of the 2 ions.
Results: The described method is highly sensitive (detection limit, 0.5 pg/mL), with a linear dynamic range of 1-5000 pg/mL. The intra- and interassay imprecisions were 4.68% and 3.88%, respectively. The values obtained correlated strongly with the GC/MS procedure (r = 0.80), but the absolute values were
4-5-fold lower, because the present method measures specifically 1 isomer of isoprostane, whereas the GC/MS method measures 4 isomers together.
Conclusions: Because of its simplicity and sensitivity, the present method provides a useful noninvasive tool for determining oxidative stress in patients.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |